Pulmonology2 years ago
FDA Expands Trikafta Approval for Cystic Fibrosis Treatment to Include Young Children
According to a press release from Vertex Pharmaceuticals, the FDA has increased the use of elexacaftor, tezacaftor, and ivacaftor in children with cystic fibrosis who are...
